Influence of Fedratinib on the Pharmacokinetics of the Transporter Probe Substrates Digoxin, Rosuvastatin, and Metformin
Clinical trial NCT04231435 · COMPLETED
Trial details
- NCT number
- NCT04231435
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-18
- Primary completion
- 2020-02-19
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.